Rilpivirine versus efavirenz with two background nucleoside or nucleotide reverse transcriptase inhibitors in treatment-naive adults infected with HIV-1 (THRIVE): a phase 3, randomised, non-inferiority trial (Q44513458)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Rilpivirine versus efavirenz with two background nucleoside or nucleotide reverse transcriptase inhibitors in treatment-naive adults infected with HIV-1 (THRIVE): a phase 3, randomised, non-inferiority trial |
scientific article |
Statements
1 reference
Rilpivirine versus efavirenz with two background nucleoside or nucleotide reverse transcriptase inhibitors in treatment-naive adults infected with HIV-1 (THRIVE): a phase 3, randomised, non-inferiority trial (English)
1 reference
Bonaventura Clotet
1 reference
Kiat Ruxrungtham
1 reference
Calvin J Cohen
1 reference
Jaime Andrade-Villanueva
1 reference
Jan Fourie
1 reference
Margaret A Johnson
1 reference
Hao Wu
1 reference
Carmen Zorrilla
1 reference
Herta Crauwels
1 reference
Laurence T Rimsky
1 reference
Simon Vanveggel
1 reference
Katia Boven
1 reference
THRIVE study group
1 reference
1 July 2011
1 reference
Identifiers
1 reference